Archives of Pediatric Infectious Diseases

Published by: Kowsar

The Validity of a Scoring System in Predicting Intravenous Immunoglobulin Treatment Failure in Children With Kawasaki Disease

Alireza Nateghian 1 , * , Roya Isa Tafreshi 1 , Arezoo Najari 2 and Atefeh Vaezi 3
Authors Information
1 Department of Pediatrics, Aliasghar Children Hospital, Iran University of Medical Sciences, Tehran, IR Iran
2 Aliasghar Children Hospital, Iran University of Medical Sciences, Tehran, IR Iran
3 Department of Social Medicine, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 01, 2016, 4 (1); e27527
  • Published Online: December 30, 2015
  • Article Type: Research Article
  • Received: February 8, 2015
  • Revised: October 9, 2015
  • Accepted: November 7, 2015
  • DOI: 10.5812/pedinfect.27527

To Cite: Nateghian A, Isa Tafreshi R, Najari A, Vaezi A. The Validity of a Scoring System in Predicting Intravenous Immunoglobulin Treatment Failure in Children With Kawasaki Disease, Arch Pediatr Infect Dis. 2016 ; 4(1):e27527. doi: 10.5812/pedinfect.27527.

Abstract
Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Tacke CE, Burgner D, Kuipers IM, Kuijpers TW. Management of acute and refractory Kawasaki disease. Expert Rev Anti Infect Ther. 2012; 10(10): 1203-15[DOI][PubMed]
  • 2. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006; 113(22): 2606-12[DOI][PubMed]
  • 3. Seki M, Kobayashi T, Kobayashi T, Morikawa A, Otani T, Takeuchi K, et al. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease. Pediatr Infect Dis J. 2011; 30(2): 145-7[DOI][PubMed]
  • 4. Cha S, Yoon M, Ahn Y, Han M, Yoon KL. Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease. J Korean Med Sci. 2008; 23(4): 718-22[DOI][PubMed]
  • 5. Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011; 158(5): 831-835000[DOI][PubMed]
  • 6. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatrics International. 2005; 47(2): 232-4[DOI]
  • 7. Sittiwangkul R, Pongprot Y, Silvilairat S, Phornphutkul C. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease. Singapore Med J. 2006; 47(9): 780-4[PubMed]
  • 8. Moffett BS, Syblik D, Denfield S, Altman C, Tejtel-Sexson K. Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database. Pediatr Cardiol. 2015; 36(2): 374-8[DOI][PubMed]
  • 9. Karimi A, Nateghian AR, KARIMI M, Shirvani B. Association Of Cardiovascular Complications With Acute Phase Response In Kawasaki Patients. Sci J Hamedan Uni Med Sci. 2002; 9(3): 17-21
  • 10. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006; 149(2): 237-40[DOI][PubMed]
  • 11. Rigante D, Valentini P, Rizzo D, Leo A, De Rosa G, Onesimo R, et al. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int. 2010; 30(6): 841-6[DOI][PubMed]
  • 12. Lee SM, Lee JB, Go YB, Song HY, Lee BJ, Kwak JH. Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease. Korean Circ J. 2014; 44(6): 415-22
  • 13. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007; 166(2): 131-7[DOI][PubMed]
  • 14. Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child. 2014; 99(1): 74-83[DOI][PubMed]
  • 15. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008; 153(1): 117-21[DOI][PubMed]
  • 16. Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, et al. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum. 2013; 65(3): 805-14[DOI][PubMed]
  • 17. Shiari R. Kawasaki Disease; A Review Article. Archives of Pediatric Infectious Diseases. 2013; 2(1): 154-9
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments